CENTRAL VENOUS CATHETER IN ONCOHEMATOLOGICAL PRACTICE (LECTURE AND OWN DATA)

  • N.A. Romanenko Russian Research Institute of Hematology and Transfusiology (Saint Petersburg). 2nd Sovetskaya, 16, Saint Petersburg, Russian Federation, 191024 https://orcid.org/0000-0002-7602-9382
Keywords: central venous catheter, pneumothorax, subclavian vein, thrombophlebitis, bloodstream infection, catheter-associated infection

Abstract

The central vein catheterization provides venous access in oncohematological patients for the administration of large volumes infusions, high-dose chemotherapy, daily administration of drugs, parenteral nutrition, and assessment of central venous pressure. The article provides information on the types of venous catheters, the technique of placing a central venous catheter (CVC) from various vascular accesses. Detailed information is provided on possible complications that arise both during the procedure and when caring for the CVC. The results of own experience of setting up CVC in 2856 patients with diseases of the blood system are also presented. It was shown that among the immediate complications, hematoma (in 4.1 % of cases), puncture of the subclavian artery (2.8 %), immediate (2.7 %) and delayed (2.7 %) bleeding, lymphorrhea (1,4 %), pain and paresthesia (1.6 %), weakness and collapse (1.2 %); less often — an allergic reaction to an anesthetic (0.1 %), pneumothorax (0.2 %), the impossibility of setting up a CVC due to the anatomical features of the patient (0.5 %), bending of the catheter (0.2 %). The delayed complications include catheter integrity failure (0.5 %), CVC extravasation (1.2 %), phlebitis, thrombophlebitis, infiltration (2.6 %), bacteremia and sepsis (2.5 %). The author has shown that the most common bloodstream infection associated with CVC is Gram-positive flora — Staphylococcus epidermidis (50.6 %), Staphylococcus aureus (9 %) and Gram-negative — Esche richia coli (15.7 %), Enterobacter spp. (9 %). Nevertheless, despite the risk of complications during central venous catheterization in patients with oncohematological profile, CVCs remain relevant, but patient preparation and quality care for CVCs are required.

References

Абдулкадыров К.М., Шмидт А.В. Центральные венозные катетеры в гематологии: приоритеты и проблемы. В кн.: Гематология: Новейший справочник. Под общ. ред. К.М. Абдулкадырова. М.: Сова. 2004: 851–89.

Романенко Н.А. Частота возникновения осложнений, связанных с катетеризацией центральной вены и катетер-ассоциированные инфекции у пациентов с заболеваниями системы крови. Вестник гематологии. 2022; 18(1): 52–3.

Сугак А.Б., Щукин В.В., Константинова А.Н., Феоктистова Е.В. Осложнения при постановке и эксплуа­тации центральных венозных катетеров. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2019; 18(1): 127–39. DOI: 10.24287/1726-1708-2019-18-1-127-139.

Чен Г., Соннендэй К.Дж, Лиллемо К.Д. Руководство по технике врачебных манипуляций. Пер. с англ. М.: Медицинская литература. 2002.

Di Carlo I., Pulvireni E., Mannino M., Toro A. Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications. Ann. Surg. Oncol. 2010; 17(6): 1649–56. DOI: 10.1245/s10434-010-1005-4.

Maki D.G., Kluger D.M., Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proc. 2006; (81): 1159–71. DOI: 10.4065/81.9.1159.

Romanenko N.A. Central vein catheterization in oncohematology patients: complication, associated with procedure and care. HemaSphere. 2022; 6(3): 1487–8. DOI: 10.1097/01.HS9.0000849280.98974.58.

Published
2024-07-30
How to Cite
Romanenko, N. (2024). CENTRAL VENOUS CATHETER IN ONCOHEMATOLOGICAL PRACTICE (LECTURE AND OWN DATA). Medicine: Theory and Practice, 9(1), 77-92. https://doi.org/10.56871/MTP.2024.70.59.009
Section
Статьи